Back to top
more

Cigna Group (CI)

(Delayed Data from NYSE)

$269.96 USD

269.96
2,153,885

-0.78 (-0.29%)

Updated Aug 6, 2025 04:00 PM ET

After-Market: $269.98 +0.02 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 1% (243 out of 246)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Anthem Buys America's 1st Choice, Expands in Medicare Market

by Zacks Equity Research

Anthem's (ANTM) acquisition of America's 1st Choice falls in line with its strategy to expand in the Medicare Advantage market.

    Zacks Equity Research

    MetLife (MET) Q4 Earnings Beat, Revenues Miss Estimates

    by Zacks Equity Research

    Robust EMEA and Latin America segments aid MetLife (MET) in Q4. However, a dull performance at U.S., Asia and MetLife Holdings partially offsets this upside.

      Zacks Equity Research

      The Zacks Analyst Blog Highlights: Cigna, Burlington Stores and Anthem

      by Zacks Equity Research

      The Zacks Analyst Blog Highlights: Cigna, Burlington Stores and Anthem

        Benjamin Rains headshot

        3 Stable Low-Beta Stocks to Buy During Volatile Markets

        by Benjamin Rains

        Markets began to rebound on Monday after their worst week in nearly two years. The Dow Jones Industrial Average and the S&P 500 both climbed over 1.30%. Still, analysts are divided over whether the recent sell-off is over just yet.

          Zacks Equity Research

          Cigna Q4 Earnings Top on Higher Enrollment, 2018 View Issued

          by Zacks Equity Research

          Cigna (CI) Q4 earnings grow on higher revenues, which gained from higher premium and fees and increase in membership.

            Zacks Equity Research

            Cigna (CI) Beats on Q4 Earnings & Revenues, Guides for 2018

            by Zacks Equity Research

            Cigna (CI) Q4 earnings gained on membership and revenue growth.

              Zacks Equity Research

              Will Higher Membership, Revenues Aid Cigna (CI) Q4 Earnings?

              by Zacks Equity Research

              Cigna's (CI) Q4 earnings should likely be aided by higher revenues from its healthcare, global supplement units, partly offset by Medicare membership loss.

                Zacks Equity Research

                Zacks Industry Outlook Highlights: Aetna, Humana, Cigna and Anthem

                by Zacks Equity Research

                Zacks Industry Outlook Highlights: Aetna, Humana, Cigna and Anthem

                  Zacks Equity Research

                  Zacks Industry Outlook Highlights: UnitedHealth, Humana, Cigna, Anthem and Centene

                  by Zacks Equity Research

                  Zacks Industry Outlook Highlights: UnitedHealth, Humana, Cigna, Anthem and Centene

                    Zacks Equity Research

                    Zacks Industry Outlook Highlights: Aetna, Cigna, UnitedHealth and CVS Health

                    by Zacks Equity Research

                    Zacks Industry Outlook Highlights: Aetna, Cigna, UnitedHealth and CVS Health

                      Zacks Equity Research

                      Will Catastrophe Loss Impact Travelers' (TRV) Q4 Earnings?

                      by Zacks Equity Research

                      Weak underwriting results and deteriorated combined ratio across segments might affect Travelers' (TRV) Q4 results.

                        Zacks Equity Research

                        3 Reasons Why Cigna (CI) is a Great Momentum Stock

                        by Zacks Equity Research

                        Cigna (CI )seems to be a great momentum stock on the back of favorable price performance both in short and long term.

                          Zacks Equity Research

                          Why the Earnings Streak Will Continue for Cigna (CI)

                          by Zacks Equity Research

                          Cigna (CI) has seen a nice short-term history of beating earnings estimates, and looks poised to crush analyst expectations in its next earnings report as well.

                            Zacks Equity Research

                            The Zacks Analyst Blog Highlights: Progressive, Cigna, Selective Insurance Group and Brighthouse Financial

                            by Zacks Equity Research

                            The Zacks Analyst Blog Highlights: Progressive, Cigna, Selective Insurance Group and Brighthouse Financial

                              Zacks Equity Research

                              Invest in These 4 Insurance Stocks Ahead of Q4 Earnings

                              by Zacks Equity Research

                              We choose four insurers with favorable characteristics to leverage investors' portfolio ahead of Q4 earnings.

                                Zacks Equity Research

                                Prudential (PRU) & Units' Ratings Retained by A.M. Best

                                by Zacks Equity Research

                                A.M. Best's rating action on Prudential (PRU) and its units reflects the company's solid operational efficiency, strong enterprise risk management, promising business profile and sturdy finances.

                                  Zacks Equity Research

                                  MTG or RDN: Which Stock is Stronger for Mortgage Insurance?

                                  by Zacks Equity Research

                                  On a comparative-analysis basis, we try and find out which stock, Radian Group (RDN) or MGIC Investment (MTG), is better positioned in terms of fundamentals.

                                    Zacks Equity Research

                                    Tenet Healthcare Grows on Acquisitions, Lower Revenues Hurt

                                    by Zacks Equity Research

                                    Tenet Healthcare (THC) gains from buyouts, divestitures and strategic initiatives. However, fall in revenues and high level of debt continue to bother.

                                      Zacks Equity Research

                                      5 Top-Ranked Insurance Stocks to Buy for 2018

                                      by Zacks Equity Research

                                      As we ring New Year, here's a list of five Top-Ranked Insurance Stocks for 2018 to make investment portfolio a compelling one for maximizing returns.

                                        Zacks Equity Research

                                        Top Ranked Growth Stocks to Buy for December 28th

                                        by Zacks Equity Research

                                        Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 28th:

                                          Zacks Equity Research

                                          Here's Why You Should Hold Onto Cboe Global Markets Stock

                                          by Zacks Equity Research

                                          Cboe Global Markets (CBOE) remains well poised for growth on the back of its strong market position and a global reach with potent proprietary products.

                                            Zacks Equity Research

                                            UnitedHealth (UNH) Arm to Buy Chilean Company for $2.8B

                                            by Zacks Equity Research

                                            UnitedHealth (UNH) is set to buy Empresas Banmedica in order to expand its international operations.

                                              Zacks Equity Research

                                              Old Republic Issues Q4 Estimates, Okays Special Dividend

                                              by Zacks Equity Research

                                              Old Republic (ORI) estimates net realized investment gains of $150 million as well as to incur $45 million of additional expense in Q4. The company also approves a special dividend of $1.00 per share.

                                                Zacks Equity Research

                                                Is Cigna Corporation (CI) a Good Stock for Value Investors?

                                                by Zacks Equity Research

                                                Let's see if Cigna Corporation (CI) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

                                                  Zacks Equity Research

                                                  The Zacks Analyst Blog Highlights: Wal-Mart, Procter & Gamble, NVIDIA, Cigna and McKesson

                                                  by Zacks Equity Research

                                                  The Zacks Analyst Blog Highlights: Wal-Mart, Procter & Gamble, NVIDIA, Cigna and McKesson